Cargando…
Oncolytic Herpes Simplex Virus Prevents Premalignant Lesions from Progressing to Cancer
Early detection and timely treatment of precancerous lesions are hallmarks of successful strategies to prevent deaths due to cancer. Oncolytic viruses are a group of promising anti-cancer agents with wide-ranging experimental and clinical efficacy against solid tumors. Previously, we have shown that...
Autores principales: | Woo, Yanghee, Reid, Vincent, Kelly, Kaitlyn J., Carlson, Diane, Yu, Zhenkun, Fong, Yuman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940689/ https://www.ncbi.nlm.nih.gov/pubmed/31909180 http://dx.doi.org/10.1016/j.omto.2019.11.003 |
Ejemplares similares
-
Oncolytic herpes simplex virus kills stem-like tumor-initiating colon cancer cells
por: Warner, Susanne G, et al.
Publicado: (2016) -
Oncolytic herpes simplex virus and immunotherapy
por: Ma, Wenqing, et al.
Publicado: (2018) -
Retargeting Strategies for Oncolytic Herpes Simplex Viruses
por: Campadelli-Fiume, Gabriella, et al.
Publicado: (2016) -
Oncolytic Herpes Simplex Virus-Based Therapies for Cancer
por: Aldrak, Norah, et al.
Publicado: (2021) -
Imaging of Lymph Node Micrometastases Using an Oncolytic Herpes Virus and [(18)F]FEAU PET
por: Brader, Peter, et al.
Publicado: (2009)